Management of Atrial Fibrillation With Flecainide : the AFFLEC Study

Completed

• Conditions: Atrial Fibrillation

• Registration Number: NCT02190175
• Lead Sponsor: Hellenic Cardiovascular Research Society

Brief Summary

This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.

Detailed Description

the study objectives are

* record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation

* study of flecainide in ST interval

Study Timeline

• Study Start: 2014-06
• Study First Submitted: 2014-07-08
• Study First Submitted QC: 2014-07-11
• Study First Posted: 2014-07-15
• Primary Completion: 2015-11
• Study Completion: 2015-12
• Status Verified: 2017-03
• Last Update Submitted: 2018-09-06
• Last Update Posted: 2018-09-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• patients with history of atrial fibrillation
• patients able to give informed consent

Exclusion Criteria

• patients with coronary disease or other cardiopathy with left heart champer affected

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ST interval and repolarization measures of myocardia in patients under treatment of flecainide	6months

Trial Locations

Locations (3)

Erythros Stavros Hospital; 🇬🇷 Athens, Greece

University Hospital of Larisa; 🇬🇷 Larisa, Greece

AHEPA University Hospital; 🇬🇷 Thessaloniki, Greece